Chukwunonso Nwabufo

Chukwunonso Nwabufo is the founder of OneDrug and a pharmaceutical sciences PhD candidate at U of T. OneDrug is a biotech startup developing smart point-of-care devices like ProbeiT to quickly identify patients at risk of adverse drug effects. By providing rapid genotype and phenotype results, they enable informed treatment decisions, support precision medicine, and reduce the global impact of ADEs.